Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Chanson

Showing results (111-120 of 363) with videos related to

Pageof 37
Sort By:
Annales D'Endocrinologie|August 22, 2018
Expert opinion on pituitary complications in immunotherapyClaire Briet, Frederique Albarel, Emmanuelle Kuhn, et al.
Endocrine|May 18, 2024
Clinical and therapeutic implications of cavernous sinus invasion in pituitary adenomasEtienne Lefevre, Fanny Chasseloup, Mirella Hage, et al.
Endocrine Reviews|September 29, 2015
Pituitary ApoplexyClaire Briet, Sylvie Salenave, Jean-François Bonneville, et al.
Journal of the Endocrine Society|December 22, 2017
A Somewhat Bizarre Case of Graves Disease Due to Vitamin TreatmentAbdallah Al-Salameh, Laurent Becquemont, Sylvie Brailly-Tabard, et al.
Clinical Endocrinology|November 18, 2003
Chromogranin A as serum marker of pituitary adenomasIlinca-Lucia Gussi, Jacques Young, Eric Baudin, et al.
Endocrine|May 15, 2013
Primary hyperparathyroidism in pregnancyGonzalo Diaz-Soto, Agnès Linglart, Marie-Victoire Sénat, et al.
Reviews in Endocrine & Metabolic Disorders|February 27, 2026
Use of osilodrostat in a block-and-replace and titration strategy for cushing's syndrome: a position paper by French expertsFrédéric Castinetti, Jérôme Bertherat, Philippe Chanson, et al.
Lancet (London, England)|April 20, 2020
Treating hypoparathyroidism with recombinant human parathyroid hormone (1-34): long-term safety concernsCécile Goujard, Sylvie Salenave, Karine Briot, et al.
The Journal of Clinical Endocrinology and Metabolism|May 6, 2004
Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled TrialsPatrick Maison, Simon Griffin, Marc Nicoue-Beglah, et al.
Endocrine|March 16, 2019
Novel PET tracers: added value for endocrine disordersSébastien Bergeret, Judith Charbit, Catherine Ansquer, et al.
Pageof 37

Showing results (111-120 of 363) with videos related to

Sort By:
Pageof 37
Annales D'Endocrinologie|August 22, 2018
Expert opinion on pituitary complications in immunotherapyClaire Briet, Frederique Albarel, Emmanuelle Kuhn, et al.
Endocrine|May 18, 2024
Clinical and therapeutic implications of cavernous sinus invasion in pituitary adenomasEtienne Lefevre, Fanny Chasseloup, Mirella Hage, et al.
Endocrine Reviews|September 29, 2015
Pituitary ApoplexyClaire Briet, Sylvie Salenave, Jean-François Bonneville, et al.
Journal of the Endocrine Society|December 22, 2017
A Somewhat Bizarre Case of Graves Disease Due to Vitamin TreatmentAbdallah Al-Salameh, Laurent Becquemont, Sylvie Brailly-Tabard, et al.
Clinical Endocrinology|November 18, 2003
Chromogranin A as serum marker of pituitary adenomasIlinca-Lucia Gussi, Jacques Young, Eric Baudin, et al.
Endocrine|May 15, 2013
Primary hyperparathyroidism in pregnancyGonzalo Diaz-Soto, Agnès Linglart, Marie-Victoire Sénat, et al.
Reviews in Endocrine & Metabolic Disorders|February 27, 2026
Use of osilodrostat in a block-and-replace and titration strategy for cushing's syndrome: a position paper by French expertsFrédéric Castinetti, Jérôme Bertherat, Philippe Chanson, et al.
Lancet (London, England)|April 20, 2020
Treating hypoparathyroidism with recombinant human parathyroid hormone (1-34): long-term safety concernsCécile Goujard, Sylvie Salenave, Karine Briot, et al.
The Journal of Clinical Endocrinology and Metabolism|May 6, 2004
Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled TrialsPatrick Maison, Simon Griffin, Marc Nicoue-Beglah, et al.
Endocrine|March 16, 2019
Novel PET tracers: added value for endocrine disordersSébastien Bergeret, Judith Charbit, Catherine Ansquer, et al.
Pageof 37